Intersect ENT, Inc. (XENT) Social Stream
Intersect ENT Inc (XENT) Price Targets From Analysts
Use the tables below to see what analysts covering Intersect ENT Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 170 days, XENT's average price target has gone up $1.21.
XENT reports an average of 8.47% for its upside potential over the past 163 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
XENT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 61 days, XENT's average broker recommendation rating worsened by 0.57.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for XENT as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Intersect ENT Inc's variance in analysts' estimates is lower than -13.83% of them.
- In terms of how Intersect ENT Inc fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is higher than 20.6% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, Intersect ENT Inc's number of analysts covering the stock is greater than 106.04% of them.
- XENT has a greater average analyst price target than 255.6% of stocks in the small market cap category.
What is the outlook for XENT? Use POWR Ratings for clearer insight into price direction.